Conatus Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$4.21M Sell
28,824
-178,170
-86% -$25.4M 4.56% 14
2017
Q3
$28.1M Sell
206,994
-209,520
-50% -$26.5M 3.39% 16
2017
Q2
$52.2M Buy
416,514
+31,658
+8% +$3.79M 4.79% 10
2017
Q1
$45.7M Buy
384,856
+74,829
+24% +$9M 3.41% 12
2016
Q4
$35.8M Buy
+310,027
New +$34.5M 2.63% 19
2013
Q4
Sell
-1,058,825
Closed -$78.2M 28
2013
Q3
$78.2M Sell
1,058,825
-264,710
-20% -$19.5M 3.3% 20
2013
Q2
$101M Buy
+1,323,535
New +$86.8M 4.21% 2

Other funds holding CME

Conatus Capital Management's CME Position: Q4 2017 in Review

Conatus Capital Management reduced its CME Group (CME) stake by 86% in Q4 2017, selling an estimated $25.4M and leaving 28,824 shares worth $4.21M. The position accounts for 4.56% of the portfolio, ranked #14.

Conatus Capital Management first reported a position in CME in Q2 2013 and has held it in 7 quarters since. The position peaked at $101M in Q2 2013. 855 funds tracked by Wall St. Rank hold CME as of Q4 2017.

  • Conatus Capital Management held 28,824 shares of CME Group worth $4.21M as of Q4 2017.
  • Conatus Capital Management sold 178,170 CME Group shares in Q4 2017, an estimated $25.4M.
  • CME Group made up 4.56% of Conatus Capital Management's portfolio in Q4 2017, its #14 holding.
  • Conatus Capital Management first reported a position in CME Group in Q2 2013 and has held it in 7 quarters since.
  • Conatus Capital Management's CME Group position peaked at $101M in Q2 2013.
  • 855 funds tracked by Wall St. Rank held CME Group as of Q4 2017.

Based on Conatus Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.